Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Reneo Pharmaceuticals, Inc. (RPHM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
4
| GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Gifted 50,000 shares
@ $0 |
|
| 06/08/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| Blunt Roshawn A. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 14,815 options to buy
@ $9.01, valued at
$133.5k
|
|
| 06/08/2023 |
4
| GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| Hoelscher Paul W. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| Muralidhar Bali (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| O'Donnell Niall (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| Seltzer Stacey Denenberg (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 06/08/2023 |
4
| Dube Eric M (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 05/10/2023 |
4
| O'Donnell Niall (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Bought 125,000 shares
@ $8, valued at
$1M
|
|
| 12/13/2022 |
4
| Lam Jennifer (VP of Finance & Administration) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.8, valued at
$162k
|
|
| 12/13/2022 |
4
| Hall Ashley (Chief Development Officer) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.8, valued at
$225k
|
|
| 12/13/2022 |
4
| FLESHER GREGORY J. (President and CEO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.8, valued at
$540k
|
|
| 12/13/2022 |
4
| Dorenbaum Alejandro (Chief Medical Officer) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Gifted 22,348 shares
@ $0
Granted 125,000 options to buy
@ $1.8, valued at
$225k
|
|
| 12/13/2022 |
4
| Cruse Michael (COO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.8, valued at
$225k
|
|
| 09/02/2022 |
4
| Cruse Michael (COO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Bought 7,500 shares
@ $3.393, valued at
$25.4k
|
|
| 09/02/2022 |
4
| GREY MICHAEL G (Executive Chairman) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Exercised 50,000 options to buy
@ $1.97, valued at
$98.5k
|
|
| 08/31/2022 |
4
| Cruse Michael (COO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Bought 83 shares
@ $3.24, valued at
$268.9
Bought 1,140 shares
@ $3.24, valued at
$3.7k
Bought 975 shares
@ $3.16, valued at
$3.1k
Bought 1,845 shares
@ $3.1938, valued at
$5.9k
Bought 3,212 shares
@ $3.209, valued at
$10.3k
|
|
| 08/02/2022 |
4
| Blunt Roshawn A. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.8, valued at
$98k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| O'Donnell Niall (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $2.09, valued at
$36.6k
|
|
| 03/04/2022 |
4
| Cruse Michael (COO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.58, valued at
$114.5k
|
|
| 01/24/2022 |
4
| Hoelscher Paul W. (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $8.01, valued at
$280.4k
|
|
| 12/14/2021 |
4
| Jindal Vineet R. (CFO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 100,000 options to buy
@ $6.69, valued at
$669k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Dorenbaum Alejandro (Chief Medical Officer) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 100,000 options to buy
@ $6.69, valued at
$669k
|
|
| 12/14/2021 |
4
| Cruse Michael (Senior VP-Corporate Operations) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 75,000 options to buy
@ $6.69, valued at
$501.8k
|
|
| 11/15/2021 |
4
| Hall Ashley (Chief Development Officer) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 180,000 options to buy
@ $8.85, valued at
$1.6M
|
|
| 08/26/2021 |
4
| Jindal Vineet R. (CFO) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $7.4353, valued at
$37.2k
|
|
|
|
|